A simple form of talking therapy, delivered by trained support workers over the telephone, reduced loneliness in older people left isolated during the pandemic, the initial results of a new study have revealed. People were contacted weekly and were encouraged to maintain their social contacts and to stick to a daily schedule, which included both […]
Home »
UK trial reinfects volunteers who have had coronavirus
The University of Oxford said Monday it has launched a trial in which people who have already had COVID-19 are deliberately reinfected. The carefully controlled study will look at the kind of immune response mounted by the volunteers. The scientists will know “exactly when the second infection occurs, and exactly how much virus they got,” […]
Carolina clinical trial tests effectiveness of mouthwash to kill coronavirus
Researchers at the University of North Carolina at Chapel Hill Adams School of Dentistry have launched a clinical trial to test whether mouthwash can reduce a person’s risk of spreading coronavirus. Laboratory experiments have shown mouthwash can quickly kill coronaviruses, but there’s no evidence mouthwash can prevent the virus from infecting people. The Adams School […]
What Happened When I Signed Up for the AstraZeneca Vaccine Trial
I was standing outside the fence at my son’s one and only swimming meet—watching through the wrought-iron bars as the swimmers raced two at a time with an open lane between them—when I heard that University of Wisconsin Hospital was seeking volunteers to test the AstraZeneca Vaccine (AZD1222). It was a few days before school […]
Gout drug tested as coronavirus treatment in large UK trial
Americans remain hopeful for coronavirus vaccine following the Thanksgiving holiday Internal medicine physician Dr. Shoshana Ungerleider calls recent vaccine developments ‘truly incredible.’ An anti-inflammatory drug widely used to treat gout and other conditions is the latest to be added to a large-scale trial in the U.K. that is investigating potential treatments for coronavirus. Researchers leading […]
Moderna coronavirus vaccine trial volunteer details experience: Nothing to fear but minor side effects
Moderna coronavirus vaccine trial volunteer shares experience Moderna COVID-19 vaccine volunteer, Jack Morningstar, shares trial experience, urges others to take on ‘Fox & Friends.’ A Moderna coronavirus vaccine trial volunteer from the University of North Carolina at Chapel Hill shared his experience with "Fox & Friends" Friday, urging everyone to get it to save lives and […]
Results from the COBRA-REDUCE trial reported
For patients undergoing percutaneous coronary intervention (PCI) that also require oral anticoagulation, treatment with a nanotechnology polymer-coated stent plus 14-day dual anti-platelet therapy (DAPT) did not reduce bleeding or establish non-inferior outcomes for thrombotic events compared with a drug-eluting stent (DES) and standard three or six-month DAPT therapy. Findings were reported today at TCT Connect, […]
Results from the VOYAGER PAD Trial reported
A large subgroup analysis of a randomized clinical trial showed neither a mortality risk nor benefit associated with the use of paclitaxel drug-coated devices (DCD) in the treatment of peripheral artery disease (PAD). The study also found that the benefit of rivaroxaban use on reducing ischemic limb and cardiovascular outcomes was consistent regardless of whether […]
NIH begins large clinical trial to test immune modulators for treatment of COVID-19
The National Institutes of Health has launched an adaptive Phase 3 clinical trial to evaluate the safety and efficacy of three immune modulator drugs in hospitalized adults with COVID-19. Some COVID-19 patients experience an immune response in which the immune system unleashes excessive amounts of proteins that trigger inflammation—called a “cytokine storm”—that can lead to […]
Medicine trial meets primary endpoint in patients with chronic kidney disease
Dapagliflozin reduces the risk of kidney failure, death from cardiovascular causes or heart failure hospitalization, and all-cause mortality in chronic kidney disease patients with or without type 2 diabetes. That’s the main result of the DAPA-CKD trial presented in a Hot Line session today at ESC Congress 2020. The DAPA-CKD trial tested the hypothesis that […]